Abstract
Neuropeptide Y (NPY) is a biologically active neuropeptide that is responsible for a large list of physiological processes. We propose a short modified fragment of NPY that should at least partially have a spectrum of biological activity of the original peptide. The compound was named nonapeptide NP9.
 The aim of our study was to investigate the ability of the modified fragment of NPY to influence spatial memory and learning.
 Materials and methods: the study was performed on 24 one-year-old random-bred female rats weight 220–250 g. The animals were divided into 3 groups of 8 rats each: treated with a solvent (0.9 % NaCl), a solution of peptide NP9 0.02 mg/kg and the drug “Semax” 0.1 mg/kg. All drugs were administered intranasally. The study of the effect of the peptide NP9 on spatial memory and learning ability was performed in the psychopharmacological test the Morris water maze. Navigation parameters were analyzed using Noldus EthoVision XT 14 video tracking software. The escape latency, the distance moved, the average velocity and the meander were recorded. An inter-quadrant analysis of rat behavior was also performed, for which the frequency of appearance and time spent in certain quadrants were recorded.
 Results: nonapeptide NP9 in the Morris water maze test demonstrated the ability to accelerate the time to find a hidden platform, reduce the distance traveled, meander, and optimize the search strategy.
 Conclusions: NP9 peptide has demonstrated the ability to positively influence learning and spatial memory. The improvement in cognitive performance of animals administered with the peptide NP9 was no less than that of the reference nootropic drug Semax. These results substantiate the feasibility of further research with the aim of pharmaceutical development of a new nootropic drug
Highlights
IntroductionMental and neurological disorders are an urgent problem. Their prevalence has increased by 16 % in recent years, with further growth expected due to population aging and the impact of adverse factors such as armed conflict and migration [1]
The aim of our study was to investigate the ability of the modified fragment of Neuropeptide Y (NPY) to influence spatial memory and learning
The length of the path that the animals traveled in search of the platform has decreased. This may mean that the animals of the peptide NP9 group remembered the location of the platform no worse than the animals of the “Semax” group, because they traveled the distance about the same, and spent more time searching for the platform due to the lower swimming speed
Summary
Mental and neurological disorders are an urgent problem. Their prevalence has increased by 16 % in recent years, with further growth expected due to population aging and the impact of adverse factors such as armed conflict and migration [1]. The prevalence of depression, anxiety and cognitive disorders among refugees is at least three times higher than in the general population [3]. The pharmacotherapy of these disorders is often ineffective and is almost always associated with a variety of adverse reactions [4] and needs to be reviewed and improved. Despite long experience in the use of peptidergic drugs for the treatment of CNS disorders, the question of their clinical effectiveness remains open. The range of such drugs in Ukraine is small. Further search and proof of the effectiveness of new peptide agents for the treatment of CNS disorders is an urgent task
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
